RS Research
Pharmaceutical company developing next generation of nanomedicines based on an innovative drug delivery platform.
RS Research has raised €12M across 2 funding rounds from 5 investors, most recently a Series A round in Dec 2021. Based in Istanbul, Türkiye; active in Healthtech. Data as of 28 Oct 2026.
Istanbul, Türkiyewww.rsresearch.net ↗
Total raised
€12M
€11,755,301
Funding rounds
2
Investors
5
distinct backers
Active since
2017-04
latest 2021-12
Funding by year
EUR raised per yearRS Research — funding by year — interactive chart.
Data table
| RS Research — funding by year | |
|---|---|
| 2017 | €1.1M |
| 2021 | €11M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-15 | Series A | €11M | Eczacıbaşı Momentum,Gen Ilac,GEN Pharmaceuticals,OneLife Ventures | View deal → |
| 2017-04-24 | Other | €1.1M | ACT Venture Capital | View deal → |
Related news
- RS Research, GEN İlaç liderliğinde 12 milyon dolar yatırım aldıwebrazzi.com · 2021-12
- finsmes.com
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Trendyol€1.6BTürkiye · E-commerce
- CMR Surgical€1.5BUK · Healthtech
- Getir€1.4BTürkiye · E-commerce
- Roivant Sciences€1.1BSwitzerland · Healthtech
Global coverage: FundingData